Discovery of new biomarkers for malignant mesothelioma

Malignant mesothelioma is an asbestos-induced, aggressive tumour with limited treatment options and very poor outcome. Currently, there are no tumour biomarkers in widespread clinical use for this disease. Soluble mesothelin is the most intensively investigated mesothelioma biomarker and has been ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Creaney, Jenette, Dick, Ian M., Robinson, Bruce W. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Pleural Diseases and Mesothelioma (G Lee, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356891/
https://www.ncbi.nlm.nih.gov/pubmed/25927434
http://dx.doi.org/10.1007/s13665-015-0106-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356891/
https://www.ncbi.nlm.nih.gov/pubmed/25927434
http://dx.doi.org/10.1007/s13665-015-0106-8

Ejemplares similares